Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Brodowicz

Showing results (21-30 of 52) with videos related to

Pageof 6
Sort By:
Cancer|May 17, 2000
Chemotherapy for the treatment of patients with primary high grade gastric B-cell lymphoma of modified Ann Arbor Stages IE and IIEM Raderer, J Valencak, C Osterreicher, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 4, 2018
The importance of jointly analyzing treatment administration and toxicity associated with targeted therapies: a case study of regorafenib in soft tissue sarcoma patientsM Longué, B Cabarrou, J Wallet, et al.
Cancer Immunology, Immunotherapy : CII|January 5, 2002
Soluble ICAM-1 in breast cancer: clinical significance and biological implicationsW J Köstler, S Tomek, T Brodowicz, et al.
Immunology|February 1, 1997
Effects of 1 alpha,25-dihydroxyvitamin D3 and cytokines on the expression of MHC antigens, complement receptors and other antigens on human blood monocytes and U937 cells: role in cell differentiation, activation and phagocytosisA Spittler, M Willheim, F Leutmezer, et al.
European Journal of Cancer (Oxford, England : 1990)|December 16, 1998
Treatment of advanced gastric cancer with oral etoposide, leucovorin and tegafur: experience with an oral modification of the etoposide, leucovorin and 5-fluorouracil (ELF) regimenM Raderer, G V Kornek, M H Hejna, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 3, 2001
Twelve-year experience with two courses of adjuvant single-agent carboplatin therapy for clinical stage I seminomaW J Reiter, T Brodowicz, S Alavi, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 8, 2001
Sequential administration of interferon-gamma, GM-CSF, and interleukin-2 in patients with metastatic renal cell carcinoma: results of a phase II trialM Schmidinger, G Steger, C Wenzel, et al.
Journal of Cancer Research and Clinical Oncology|May 14, 2013
The Austrian experience with trabectedin in non-selected patients with metastatic soft tissue sarcoma (STS)F Ploner, W Lamm, S Schur, et al.
Anti-Cancer Drugs|June 1, 2000
Vinorelbine and interferon-alpha2c as second-line therapy in metastatic renal cell carcinomaM Schmidinger, G G Steger, A C Budinsky, et al.
British Journal of Cancer|July 29, 1999
Inhibition of proliferation and induction of apoptosis in soft tissue sarcoma cells by interferon-alpha and retinoidsT Brodowicz, C Wiltschke, D Kandioler-Eckersberger, et al.
Pageof 6

Showing results (21-30 of 52) with videos related to

Sort By:
Pageof 6
Cancer|May 17, 2000
Chemotherapy for the treatment of patients with primary high grade gastric B-cell lymphoma of modified Ann Arbor Stages IE and IIEM Raderer, J Valencak, C Osterreicher, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 4, 2018
The importance of jointly analyzing treatment administration and toxicity associated with targeted therapies: a case study of regorafenib in soft tissue sarcoma patientsM Longué, B Cabarrou, J Wallet, et al.
Cancer Immunology, Immunotherapy : CII|January 5, 2002
Soluble ICAM-1 in breast cancer: clinical significance and biological implicationsW J Köstler, S Tomek, T Brodowicz, et al.
Immunology|February 1, 1997
Effects of 1 alpha,25-dihydroxyvitamin D3 and cytokines on the expression of MHC antigens, complement receptors and other antigens on human blood monocytes and U937 cells: role in cell differentiation, activation and phagocytosisA Spittler, M Willheim, F Leutmezer, et al.
European Journal of Cancer (Oxford, England : 1990)|December 16, 1998
Treatment of advanced gastric cancer with oral etoposide, leucovorin and tegafur: experience with an oral modification of the etoposide, leucovorin and 5-fluorouracil (ELF) regimenM Raderer, G V Kornek, M H Hejna, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 3, 2001
Twelve-year experience with two courses of adjuvant single-agent carboplatin therapy for clinical stage I seminomaW J Reiter, T Brodowicz, S Alavi, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 8, 2001
Sequential administration of interferon-gamma, GM-CSF, and interleukin-2 in patients with metastatic renal cell carcinoma: results of a phase II trialM Schmidinger, G Steger, C Wenzel, et al.
Journal of Cancer Research and Clinical Oncology|May 14, 2013
The Austrian experience with trabectedin in non-selected patients with metastatic soft tissue sarcoma (STS)F Ploner, W Lamm, S Schur, et al.
Anti-Cancer Drugs|June 1, 2000
Vinorelbine and interferon-alpha2c as second-line therapy in metastatic renal cell carcinomaM Schmidinger, G G Steger, A C Budinsky, et al.
British Journal of Cancer|July 29, 1999
Inhibition of proliferation and induction of apoptosis in soft tissue sarcoma cells by interferon-alpha and retinoidsT Brodowicz, C Wiltschke, D Kandioler-Eckersberger, et al.
Pageof 6